**Author details**

Cristiano Amarelli<sup>1</sup> \*, Francesco Musumeci2 , Antonio Loforte<sup>3</sup> , Andrea Montalto<sup>2</sup> , Sveva Di Franco<sup>4</sup> and Jaime Hernandez-Montfort<sup>5</sup>

\*Address all correspondence to: camarell@tiscali.it

1 Department of Cardiac Surgery and Transplants, Monaldi Azienda dei Colli, Napoli, Italy

[7] Beely BM, Campbell JE, Meyer A, Langer T, Negaard K, Chung KK, et al. Electron microscopy as a tool for assessment of anticoagulation strategies during extracorporeal life support: The proof is on the membrane. ASAIO Journal. 2016;**62**(5):525-532. DOI: 10.1097/MAT.0000000000000394. Retrieved from: https://journals.lww.com/asaiojournal/

Flow Optimization, Management, and Prevention of LV Distention during VA-ECMO

http://dx.doi.org/10.5772/intechopen.80265

205

Fulltext/2016/09000/Electron\_Microscopy\_as\_a\_Tool\_for\_Assessment\_of.5.aspx

Adhesion\_as\_an\_Indicator\_of\_Oxygenator.4.aspx

Intensive Care. 2015;**3**(1). DOI: 10.1186/s40560-014-0069-9

2015;**187**(1):620-627. DOI: 10.1016/j.ijcard.2015.03.283

Failure. 2017;**19**(3):404-412. DOI: 10.1002/ejhf.668

DOI: 10.1186/s13054-017-1633-1

10.1097/MAT.0b013e31829f0e52

of print]

[8] Wilm J, Philipp A, Müller T, Bredthauer A, Gleich O, Schmid C, et al. Leukocyte adhesion as an indicator of oxygenator thrombosis during extracorporeal membrane oxygenation therapy? ASAIO Journal. 2018;**64**(1):24-30. DOI: 10.1097/MAT.0000000000000586. Retrieved from https://journals.lww.com/asaiojournal/Fulltext/2018/01000/Leukocyte\_

[9] Karagiannidis C, Brodie D, Strassmann S, et al. Extracorporeal membrane oxygenation: Evolving epidemiology and mortality. Intensive Care Medicine. 2016;**42**:889-896

[10] Smith M, Vukomanovic A, Brodie D, Thiagarajan R, Rycus P, Buscher H. Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: An analysis of the extracorporeal life support organization (ELSO) registry. Critical Care. 2017;**21**(1):45.

[11] Nakamura T, Ishida K, Taniguchi Y, Nakagawa T, Seguchi M, Wada H. Prognosis of patients with fulminant myocarditis managed by peripheral venoarterial extracorporeal membranous oxygenation support: A retrospective single-center study. Journal of

[12] Rousse N, Juthier F, Pinçon C, Hysi I, Banfi C, Robin E, et al. ECMO as a bridge to decision: Recovery, VAD, or heart transplantation? International Journal of Cardiology.

[13] Durinka JB, Bogar LJ, Hirose H, Brehm C, Koerner MM, Pae WE, et al. End-organ recovery is key to success for extracorporeal membrane oxygenation as a bridge to implantable left ventricular assist device. ASAIO Journal (American Society for Artificial Internal

[14] Cheng A, Swartz MF, Massey HT. Impella to unload the left ventricle during peripheral extracorporeal membrane oxygenation. ASAIO Journal. 2013;**59**(5):533-536. DOI:

[15] Pappalardo F, Schulte C, Pieri M, Schrage B, Contri R, Soeffker G, et al. Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. European Journal of Heart

[16] Patel SM, Lipinski J, Al-Kindi SG, Patel T, Saric P, Li J, et al. Simultaneous venoarterial extracorporeal membrane oxygenation and percutaneous left ventricular decompression therapy with impella is associated with improved outcomes in refractory cardiogenic shock. ASAIO Journal. 2018:1. DOI: 10.1097/MAT.0000000000000767. [Epub ahead

Organs: 1992). 2014;**60**(2):189-192. DOI: 10.1097/MAT.0000000000000043

2 Department of Heart and Vessels, Cardiac Surgery Unit and Heart Transplantation Center, S. Camillo-Forlanini Hospital, Rome, Italy

3 Department of Cardiovascular Surgery and Transplantation, S. Orsola-Malpighi Hospital, Bologna University, Bologna, Italy

4 Department of Anaesthesiology and Critical Care Medicine, L. Vanvitelli University, Naples, Italy

5 Department of Cardiology, University of Texas Medical Branch, Galveston, USA
